171 related articles for article (PubMed ID: 28213807)
1. In liver metastases from small intestinal neuroendocrine tumors, SSTR2A expression is heterogeneous.
Charoenpitakchai M; Liu E; Zhao Z; Koyama T; Huh WJ; Berlin J; Hande K; Walker R; Shi C
Virchows Arch; 2017 May; 470(5):545-552. PubMed ID: 28213807
[TBL] [Abstract][Full Text] [Related]
2. Comparing of IRS and Her2 as immunohistochemical scoring schemes in gastroenteropancreatic neuroendocrine tumors.
Kaemmerer D; Peter L; Lupp A; Schulz S; Sänger J; Baum RP; Prasad V; Hommann M
Int J Clin Exp Pathol; 2012; 5(3):187-94. PubMed ID: 22558472
[TBL] [Abstract][Full Text] [Related]
3. Somatostatin receptor SSTR2A and SSTR5 expression in neuroendocrine breast cancer.
Terlević R; Perić Balja M; Tomas D; Skenderi F; Krušlin B; Vranic S; Demirović A
Ann Diagn Pathol; 2019 Feb; 38():62-66. PubMed ID: 30476894
[TBL] [Abstract][Full Text] [Related]
4. Somatostatin receptor immunohistochemistry in neuroendocrine tumors: comparison between manual and automated evaluation.
Kaemmerer D; Athelogou M; Lupp A; Lenhardt I; Schulz S; Luisa P; Hommann M; Prasad V; Binnig G; Baum RP
Int J Clin Exp Pathol; 2014; 7(8):4971-80. PubMed ID: 25197368
[TBL] [Abstract][Full Text] [Related]
5. Frequent expression of somatostatin receptor 2a in olfactory neuroblastomas: a new and distinctive feature.
Czapiewski P; Kunc M; Gorczyński A; Haybaeck J; Okoń K; Reszec J; Lewczuk A; Dzierzanowski J; Karczewska J; Biernat W; Turri-Zanoni M; Castelnuovo P; Taverna C; Franchi A; La Rosa S; Sessa F; Klöppel G
Hum Pathol; 2018 Sep; 79():144-150. PubMed ID: 29807052
[TBL] [Abstract][Full Text] [Related]
6. Analysis of somatostatin receptor 2A immunohistochemistry, RT-qPCR, and in vivo PET/CT data in patients with pancreatic neuroendocrine neoplasm.
Kaemmerer D; Wirtz RM; Fischer EK; Hommann M; Sänger J; Prasad V; Specht E; Baum RP; Schulz S; Lupp A
Pancreas; 2015 May; 44(4):648-54. PubMed ID: 25872131
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical expression of somatostatin type 2A receptor in neuroendocrine tumors.
Kimura N; Pilichowska M; Date F; Kimura I; Schindler M
Clin Cancer Res; 1999 Nov; 5(11):3483-7. PubMed ID: 10589762
[TBL] [Abstract][Full Text] [Related]
8. High interlaboratory and interobserver agreement of somatostatin receptor immunohistochemical determination and correlation with response to somatostatin analogs.
Kasajima A; Papotti M; Ito W; Brizzi MP; La Salvia A; Rapa I; Tachibana T; Yazdani S; Sasano H; Volante M
Hum Pathol; 2018 Feb; 72():144-152. PubMed ID: 29180250
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical expression of somatostatin type 2A receptor in neuroendocrine carcinoma of uterine cervix.
Kajiwara H; Hirabayashi K; Miyazawa M; Nakamura N; Hirasawa T; Muramatsu T; Mikami M; Yasuda M; Osamura RY
Arch Gynecol Obstet; 2009 Apr; 279(4):521-5. PubMed ID: 18726606
[TBL] [Abstract][Full Text] [Related]
10. Gene expression of somatostatin receptor subtypes SSTR2a, SSTR3 and SSTR5 in peripheral blood of neuroendocrine lung cancer affected patients.
Muscarella LA; D'Alessandro V; la Torre A; Copetti M; De Cata A; Parrella P; Sperandeo M; Pellegrini F; Frusciante V; Maiello E; Merla G; Fazio VM; Vendemiale G
Cell Oncol (Dordr); 2011 Oct; 34(5):435-41. PubMed ID: 21503779
[TBL] [Abstract][Full Text] [Related]
11. Expression of potential therapeutic target SSTR2a in primary and metastatic non-keratinizing nasopharyngeal carcinoma.
Tao L; Chen Y; Shi X; Yu G; Yin W; Huang Y
Virchows Arch; 2020 Oct; 477(4):573-579. PubMed ID: 32328798
[TBL] [Abstract][Full Text] [Related]
12. Expression of Somatostatin Receptor Type 2A and PTEN in Neuroendocrine Neoplasms Is Associated with Tumor Grade but Not with Site of Origin.
Wada H; Matsuda K; Akazawa Y; Yamaguchi Y; Miura S; Ueki N; Kinoshita A; Yoshiura K; Kondo H; Ito M; Nagayasu T; Nakashima M
Endocr Pathol; 2016 Sep; 27(3):179-87. PubMed ID: 27256098
[TBL] [Abstract][Full Text] [Related]
13. HSP90 expression and early recurrence in gastroenteropancreatic neuroendocrine tumors: Potential for a novel therapeutic target.
Gamboa AC; Ethun CG; Postlewait LM; Lopez-Aguiar AG; Zhelnin K; Krasinskas A; El-Rayes BF; Russell MC; Kooby DA; Staley CA; Cardona K; Maithel SK
Surg Oncol; 2020 Dec; 35():460-465. PubMed ID: 33080545
[TBL] [Abstract][Full Text] [Related]
14. Expression Pattern of CDX2, Estrogen and Progesterone Receptors in Primary Gastroenteropancreatic Neuroendocrine Tumors and Metastases.
Zimmermann N; Lazar-Karsten P; Keck T; Billmann F; Schmid S; Brabant G; Thorns C
Anticancer Res; 2016 Mar; 36(3):921-4. PubMed ID: 26976979
[TBL] [Abstract][Full Text] [Related]
15. mTOR pathway and somatostatin receptors expression intratumor-heterogeneity in ileal NETs.
Borga C; Dal Pozzo CA; Trevellin E; Bergamo F; Murgioni S; Milanetto AC; Pasquali C; Cillo U; Munari G; Martini C; De Carlo E; Zagonel V; Guzzardo V; Pennelli G; Dei Tos AP; Vettor R; Fassan M
Endocr Relat Cancer; 2021 Jun; 28(7):449-456. PubMed ID: 33974555
[TBL] [Abstract][Full Text] [Related]
16. Differential Protein Expression in Small Intestinal Neuroendocrine Tumors and Liver Metastases.
Kim MK; Ye F; Wang D; Cui M; Ward SC; Warner RR; Roayaie S; Shafir M; Schwartz M; Zhang D; Itzkowitz S
Pancreas; 2016 Apr; 45(4):528-32. PubMed ID: 26474427
[TBL] [Abstract][Full Text] [Related]
17. An algorithmic approach utilizing CK7, TTF1, beta-catenin, CDX2, and SSTR2A can help differentiate between gastrointestinal and pulmonary neuroendocrine carcinomas.
Yu S; Hornick JL; Gonzalez RS
Virchows Arch; 2021 Sep; 479(3):481-491. PubMed ID: 33733343
[TBL] [Abstract][Full Text] [Related]
18. Inverse expression of somatostatin and CXCR4 chemokine receptors in gastroenteropancreatic neuroendocrine neoplasms of different malignancy.
Kaemmerer D; Träger T; Hoffmeister M; Sipos B; Hommann M; Sänger J; Schulz S; Lupp A
Oncotarget; 2015 Sep; 6(29):27566-79. PubMed ID: 26259237
[TBL] [Abstract][Full Text] [Related]
19. Clinical Usefulness of Somatostatin Receptor Scintigraphy in Japanese Patients with Gastroenteropancreatic Neuroendocrine Tumors.
Hasegawa S; Kobayashi N; Tokuhisa M; Goto A; Takano S; Takada Y; Kaneta T; Mori R; Matsuyama R; Endo I; Yamanaka S; Nakajima A; Inoue T; Ichikawa Y
Digestion; 2017; 96(1):13-20. PubMed ID: 28609761
[TBL] [Abstract][Full Text] [Related]
20. Should Ki67 immunohistochemistry be performed on all lesions in multifocal small intestinal neuroendocrine tumours?
Numbere N; Huber AR; Shi C; Cates JMM; Gonzalez RS
Histopathology; 2019 Feb; 74(3):424-429. PubMed ID: 30326145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
